KROLL MARK W

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
17
Insider Sells Sum
$11.46M

Insider Activity of KROLL MARK W

The largest sale of all time was on 2012-05-04 and amounted to 40000 shares of Haemonetics Corporation for $2.4M.

Biography of KROLL MARK W

No biography is available at this moment.

2023-03-07SaleAxon Enterprise, Inc.
AXON
director
3,549
0.0049%
$220.73$783,361-3.01%
2022-08-15SaleHaemonetics Corporation
HAE
8,016
0.0153%
$73.71$590,859+8.76%
2022-06-08SaleAxon Enterprise, Inc.
AXON
3,159
0.0044%
$102.82$324,796+66.9%
2021-05-26SaleHaemonetics Corporation
HAE
director
11,813
0.023%
$55.10$650,896+5.68%
2021-05-12SaleAxon Enterprise, Inc.
AXON
director
4,204
0.0065%
$124.94$525,260+24.5%
2020-11-16SaleAxon Enterprise, Inc.
AXON
director
2,993
0.0049%
$120.44$360,477+37.9%
2020-04-09SaleHaemonetics Corporation
HAE
director
10,902
0.022%
$102.00$1.11M+6.11%
2019-11-13SaleAxon Enterprise, Inc.
AXON
director
4,168
0.007%
$64.30$267,987+26.51%
2018-11-07SaleHaemonetics Corporation
HAE
director
10,707
0.0206%
$114.00$1.22M-10.3%
2018-08-20SaleAxon Enterprise, Inc.
AXON
director
7,097
0.0122%
$64.34$456,621-6.14%
2018-01-02SaleHaemonetics Corporation
HAE
director
7,118
0.0135%
$63.00$448,434+48.13%
2017-05-15SaleHaemonetics Corporation
HAE
director
8,580
0.0163%
$41.49$355,982+30.81%
2015-02-27SaleHaemonetics Corporation
HAE
director
11,328
0.0221%
$44.80$507,483-18.98%
2014-12-16SaleAxon Enterprise, Inc.
AXON
director
3,100
0.0059%
$22.85$70,835+10.85%
2012-11-19SaleHaemonetics Corporation
HAE
director
9,184
0.0285%
$65.03$597,190+0.89%
2012-11-16SaleHaemonetics Corporation
HAE
director
12,000
0.0382%
$66.22$794,593+1.81%
2012-05-04SaleHaemonetics Corporation
HAE
director
40,000
0.132%
$59.93$2.4M+12.13%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.